Fewer CD8+ T cells and more Foxp3+ Tregs were present in the high LLT1TC group (tumor front: p = 0.071 and tumor center: p = 0.637; Figure 3B,C), suggesting that LLT1TC high patients might have an immunosuppressive TME in situ. This evidence concerns the gene CD8A and neoplasm.